ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rayaldee 30 µg, Weichkapseln retardiert - 30
67614001 Vifor Fresenius Medical Care Renal Pharma Ltd.
Rayaldee 30 µg, Weichkapseln retardiert22.12.2020
  22.12.2020
Calcifediol (H05BX05) 
WHO-DDD21.12.2025
07.02.30.30
07.02.30. 
B  
Yes 
IPCI
88.18Yes
    
10 %112.30
7680676140014Synthetika
  
Composition
calcifediolum 30 µg ut calcifediolum monohydricum, paraffinum solidum, paraffinum liquidum, hypromellosum, glyceroli monostearas 40-55, macrogolglyceridorum laurates, ethanolum anhydricum 3.944 mg, E 321, Kapselhülle: amylum hydroxypropylum, carrageenanum, sorbitolum liquidum partim deshydricum corresp. sorbitolum 18 mg, dinatrii phosphas corresp. natrium 0.3 mg, titanii dioxidum, E 133, aqua purificata pro capsula.
Packungsbestandteile
Weichkapseln retardiert 
 
Active AgentDose
Calcifediolum30 µg
BAG: Active AgentDose
Calcifediolum30 mcg
 
Inactive agentsDoseadditional_information
Amylum Hydroxypropylum Kapselhülle
Aqua Purificata pro Capsula  
Carrageenanum  
Disodium Phosphate  
E 133 color.
E 321  
Ethanol Anhydrate3.944 mg 
Glyceroli Monostearas40-55 
Hypromellosum  
Macrogolglyceridorum Laurates  
Paraffine Liquide  
Paraffinum Solidum  
Sorbitolum Liquidum Partim Deshydricum  
Titanium Dioxide  
 
Source
Data was imported : 05.05.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home